A sad story of a young girl in need of experimental liver transplant.
Similar Posts:
- Steve Jobs received a new liver, and the ethics surrounding his transplant
- Hydroxycut causes liver damage, and why we need to regulate supplements
- Texting young liver transplant patients to take their medications
KevinMD.com on Facebook
{ 2 comments }
Insurers make no claim to “do no harm.” Others do that instead. Perhaps they should be questioned in regards to why they did not waive their customary fees and “do no harm” in this case.
“Do no harm” is not the ethical principle involved here (unless you consider the procedure experimental and possibly harmful). From wikipedia: “Nonmaleficence is distinguished from beneficence by doing no harm — it does not imply an act toward the good”
Comments on this entry are closed.